Contemporary Clinical Dentistry

ORIGINAL ARTICLE
Year
: 2018  |  Volume : 9  |  Issue : 4  |  Page : 592--596

Osteogenic differentiation of human amniotic mesenchymal stem cells in chitosan-carbonate apatite scaffold (in vivo study)


Michael Josef Kridanto Kamadjaja1, Sherman Salim2, Fedik Abdul Rantam3, Ni Putu Mira Sumarta4 
1 Department of Prosthodontic, Faculty of Dental Medicine; Stem Cell Research and Development Center, Universitas Airlangga, Surabaya, Indonesia
2 Department of Prosthodontic, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
3 Stem Cell Research and Development Center, Universitas Airlangga; Regenerative Medicine and Stem Cell Center, Dr. Soetomo National Hospital; Department of Virology, Immunology and Microbiology, Faculty of Veterinary - Universitas Airlangga, Surabaya, Indonesia
4 Department of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia

Correspondence Address:
Dr. Michael Josef Kridanto Kamadjaja
Prof. Dr. Moestopo 47, Surabaya, East Java 60132
Indonesia

Background: Studies of bone tissue engineering as a viable alternative to autogenous bone graft show promising results, although its mechanism and effectiveness remain only partially understood. Purpose: to explain the osteogenic differentiation of scaffold chitosan (Ch)–carbonate apatite (CA) in seeding with human amniotic mesenchymal stem cells (hAMSCs) on the regeneration of calvarial bone defects in rats. Materials and Methods: Shitosan-Carbonate Apatite (Ch-CA) scaffold was created by means of a freeze-drying method. Twenty Wistar rats were randomly divided into two groups: control and treatment. Defects were created in the calvarial bone of each treatment group with a scaffold subsequently implanted. After 8 weeks, the rats were terminated for histology and immunohistochemistry examination. Results: Expressions of vascular endothelial growth factor, bone morphogenetic protein2, Runt-related transcription factor 2 (RUNX2), and angiogenesis occurred earlier in the tissue-engineered group than that in the control group. An 8-week analysis also showed that the expression of RUNX2, alkaline phosphatase, osteocalcin, and collagen type 1 was at more elevated levels in the treatment group than that in the control group. Conclusion: These results showed that the combination of hAMSCs and Ch-CA scaffold may become one of the candidates for bone tissue engineering.


How to cite this article:
Kamadjaja MJ, Salim S, Rantam FA, Sumarta NM. Osteogenic differentiation of human amniotic mesenchymal stem cells in chitosan-carbonate apatite scaffold (in vivo study).Contemp Clin Dent 2018;9:592-596


How to cite this URL:
Kamadjaja MJ, Salim S, Rantam FA, Sumarta NM. Osteogenic differentiation of human amniotic mesenchymal stem cells in chitosan-carbonate apatite scaffold (in vivo study). Contemp Clin Dent [serial online] 2018 [cited 2019 Dec 16 ];9:592-596
Available from: http://www.contempclindent.org/article.asp?issn=0976-237X;year=2018;volume=9;issue=4;spage=592;epage=596;aulast=Kamadjaja;type=0